Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Lebwohl David Create: Alert

All | News | Filings
Date FiledTypeDescription
01/06/2023 4 Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Sold 2,574 shares @ $37.21, valued at $95.8k
01/04/2023 4 Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Exercised 3,187 restricted stock units @ $0
03/04/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
03/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/09/2021 4 Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Sold 1,200 shares @ $131.71, valued at $158.1k
Sold 452 shares @ $132.62, valued at $59.9k
Sold 548 shares @ $134.07, valued at $73.5k
Sold 200 shares @ $135.34, valued at $27.1k
Exercised 2,400 options to buy @ $12.62, valued at $30.3k
10/15/2021 4 Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Sold 551 shares @ $126.92, valued at $69.9k
Sold 849 shares @ $127.81, valued at $108.5k
Sold 225 shares @ $129.01, valued at $29k
Sold 525 shares @ $129.83, valued at $68.2k
Sold 250 shares @ $130.47, valued at $32.6k
Exercised 2,400 options to buy @ $12.62, valued at $30.3k
09/27/2021 4 Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Exercised 7,923 options to buy @ $12.62, valued at $100k
09/23/2021 4 Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Sold 2,400 shares @ $149.81, valued at $359.5k
Exercised 2,400 options to buy @ $12.62, valued at $30.3k
09/01/2021 4 Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Sold 200 shares @ $155.43, valued at $31.1k
Sold 700 shares @ $156.7, valued at $109.7k
Sold 250 shares @ $157.6, valued at $39.4k
Sold 1,100 shares @ $159.19, valued at $175.1k
Sold 150 shares @ $160.1, valued at $24k
Exercised 2,400 options to buy @ $12.62, valued at $30.3k
08/11/2021 4 Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Sold 2,400 shares @ $164.05, valued at $393.7k
Exercised 2,400 options to buy @ $12.62, valued at $30.3k
03/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2020 4 Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Granted 200,000 options to buy @ $12.62, valued at $2.5M
05/05/2020 3 Lebwohl David (EVP, Chief Medical Officer) has filed a Form 3 on Intellia Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy